1. Home
  2. SYBX vs LIQT Comparison

SYBX vs LIQT Comparison

Compare SYBX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • LIQT
  • Stock Information
  • Founded
  • SYBX N/A
  • LIQT 2004
  • Country
  • SYBX United States
  • LIQT Denmark
  • Employees
  • SYBX N/A
  • LIQT N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • LIQT Industrial Machinery/Components
  • Sector
  • SYBX Health Care
  • LIQT Technology
  • Exchange
  • SYBX Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • SYBX 16.4M
  • LIQT 16.1M
  • IPO Year
  • SYBX N/A
  • LIQT N/A
  • Fundamental
  • Price
  • SYBX N/A
  • LIQT N/A
  • Analyst Decision
  • SYBX
  • LIQT Strong Buy
  • Analyst Count
  • SYBX 0
  • LIQT 2
  • Target Price
  • SYBX N/A
  • LIQT $4.80
  • AVG Volume (30 Days)
  • SYBX 17.3K
  • LIQT 13.9K
  • Earning Date
  • SYBX 11-11-2025
  • LIQT 11-13-2025
  • Dividend Yield
  • SYBX N/A
  • LIQT N/A
  • EPS Growth
  • SYBX N/A
  • LIQT N/A
  • EPS
  • SYBX N/A
  • LIQT N/A
  • Revenue
  • SYBX N/A
  • LIQT $15,459,242.00
  • Revenue This Year
  • SYBX N/A
  • LIQT $36.89
  • Revenue Next Year
  • SYBX N/A
  • LIQT $16.33
  • P/E Ratio
  • SYBX N/A
  • LIQT N/A
  • Revenue Growth
  • SYBX N/A
  • LIQT N/A
  • 52 Week Low
  • SYBX $0.90
  • LIQT $1.34
  • 52 Week High
  • SYBX $1.96
  • LIQT $3.11
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 57.52
  • LIQT N/A
  • Support Level
  • SYBX $1.61
  • LIQT N/A
  • Resistance Level
  • SYBX $1.74
  • LIQT N/A
  • Average True Range (ATR)
  • SYBX 0.07
  • LIQT 0.00
  • MACD
  • SYBX -0.01
  • LIQT 0.00
  • Stochastic Oscillator
  • SYBX 50.00
  • LIQT 0.00

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: